HCM
Hamlin Capital Management’s GSK GSK Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-1,772,997
| Closed | -$72M | – | 41 |
|
|
2017
Q3 | $72M | Buy |
1,772,997
+7,882
| +0.4% | +$320K | 2.92% | 19 |
|
|
2017
Q2 | $76.1M | Buy |
1,765,115
+3,003
| +0.2% | +$129K | 3.18% | 18 |
|
|
2017
Q1 | $74.3M | Buy |
1,762,112
+290,210
| +20% | +$12.2M | 3.14% | 16 |
|
|
2016
Q4 | $56.7M | Sell |
1,471,902
-12,428
| -0.8% | -$479K | 2.54% | 23 |
|
|
2016
Q3 | $64M | Buy |
1,484,330
+21,182
| +1% | +$914K | 2.96% | 11 |
|
|
2016
Q2 | $63.4M | Buy |
1,463,148
+9,117
| +0.6% | +$395K | 3.07% | 15 |
|
|
2016
Q1 | $59M | Sell |
1,454,031
-20,854
| -1% | -$846K | 2.98% | 18 |
|
|
2015
Q4 | $59.5M | Buy |
1,474,885
+109,000
| +8% | +$4.4M | 3.22% | 15 |
|
|
2015
Q3 | $52.5M | Sell |
1,365,885
-28,655
| -2% | -$1.1M | 2.9% | 17 |
|
|
2015
Q2 | $58.1M | Buy |
1,394,540
+13,984
| +1% | +$582K | 2.93% | 13 |
|
|
2015
Q1 | $63.7M | Buy |
1,380,556
+119,375
| +9% | +$5.51M | 3.36% | 7 |
|
|
2014
Q4 | $53.9M | Buy |
1,261,181
+43,311
| +4% | +$1.85M | 3.01% | 15 |
|
|
2014
Q3 | $56M | Buy |
1,217,870
+248,240
| +26% | +$11.4M | 3.36% | 5 |
|
|
2014
Q2 | $51.9M | Buy |
969,630
+88,790
| +10% | +$4.75M | 2.91% | 13 |
|
|
2014
Q1 | $47.1M | Buy |
880,840
+42,410
| +5% | +$2.27M | 3.02% | 15 |
|
|
2013
Q4 | $44.8M | Buy |
838,430
+39,605
| +5% | +$2.11M | 3.05% | 11 |
|
|
2013
Q3 | $40.1M | Buy |
798,825
+33,930
| +4% | +$1.7M | 3% | 19 |
|
|
2013
Q2 | $38.2M | Buy |
+764,895
| New | +$38.2M | 3.12% | 13 |
|